Oxford Immuniotech

Oxford Immunotec is a global high-growth diagnostics company focused on developing and commercializing proprietary tests for underserved immune-regulated conditions. The company's core technology, the T-SPOT platform, measures the responses of specific immune cells (T cells) to provide a more accurate picture of a patient's immune status than traditional blood tests. Its flagship product, the T-SPOT.TB test, is used worldwide for the diagnosis of tuberculosis infection. Beyond TB, the company has expanded its portfolio to include assays for COVID-19 and other infectious diseases, leveraging its expertise in T cell immunology.